IB
Ideaya Biosciences Inc
🇩🇪XFRA.30JGermanyHealthcare
€32.54EURup +0.38 (+1.18%)After-hoursEnd of day8:11 PM
Price€32.54+0.38 (+1.18%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US45166A1025
- CUSIP
- Not reported
Company
- Employees
- 145
- Headquarters
- South San Francisco, United States
- Website
- https://www.ideayabio.com
- CEO
- Mr. Yujiro S. Hata
Market
- Shares outstanding
- 96.5M
- Market cap
- €3.14B
Key dates
- Next earnings
- Nov 9, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €3.14B
- EPS LTM
- -$1.90
- P/E LTM
- -19.60
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $234.13M+3,244.67%up year on year
- Net income
- -$175.02M+47.25%up year on year
- Gross margin
- -13.32%+99.33%up year on year
- Free cash flow
- -$190.01M+36.08%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.